- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
USDL to buy stakes in center firms
Imaging services firm US Diagnostic Labs has signed agreementsto buy controlling interests in two center companies, one a multimodalityimaging center and the other a radiation therapy company. USDL of West Palm Beach, FL, announced this month that it
Imaging services firm US Diagnostic Labs has signed agreementsto buy controlling interests in two center companies, one a multimodalityimaging center and the other a radiation therapy company.
USDL of West Palm Beach, FL, announced this month that it intendsto purchase an 80% stake in Charleston Diagnostic Imaging of Charleston,SC. The center has revenues of $3.6 million and net income ofover $800,000 annually.
In addition, USDL agreed to buy a 50.1% interest in RadiationOncology Centers for $2.6 million. ROC operates three radiationtherapy centers in Northern California. USDL, which manages 15wholly owned or majority-owned centers, said that it intends toexpand into oncology practice management.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
